Design and synthesis of (ant)-agonists that alter appetite and adiposity.

Van der Ploeg, Lex H T; Kanatani, Akio; MacNeil, Douglas; Ming Fong, Tung; Strack, Alison; Nargund, Ravi; Guan, Xiao-Ming

Van der Ploeg, Lex H T; Kanatani, Akio; MacNeil, Douglas; Ming Fong, Tung; Strack, Alison; Nargund, Ravi; Guan, Xiao-Ming.

Affiliation

Van der Ploeg LH; Merck Research Laboratories, Boston, MA, USA. lex_van_der_ploeg@merck.com

Prog Brain Res ; 153: 107-18, 2006.

Article in En | MEDLINE | ID: mdl-16876570

Subject(s)

Adiposity/drug effects; Anti-Obesity Agents; Appetite/drug effects; Drug Design; Animals; Anti-Obesity Agents/chemical synthesis; Anti-Obesity Agents/chemistry; Anti-Obesity Agents/pharmacology; Drug Interactions; Humans; Neuropeptide Y/agonists; Neuropeptide Y/antagonists & inhibitors; Receptor, Melanocortin, Type 4/agonists; Receptor, Melanocortin, Type 4/antagonists & inhibitors

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Appetite / Drug Design / Anti-Obesity Agents / Adiposity Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2006 Type: Article

Search on Google

XML

PubMed Links